Zobrazeno 1 - 10 of 20 pro vyhledávání: '"Joseph Larsen"'
3
Akademický článek
Workshop on Treatment of and Postexposure Prophylaxis for Burkholderia pseudomallei and B. mallei Infection, 2010
Autor: Rebecca Lipsitz, Susan Garges, Rosemarie Aurigemma, Prasith Baccam, David D. Blaney, Allen C. Cheng, Bart J. Currie, David Dance, Jay E. Gee, Joseph Larsen, Direk Limmathurotsakul, Meredith G. Morrow, Robert Norton, Elizabeth O’Mara, Sharon J. Peacock, Nicki Pesik, L. Paige Rogers, Herbert P. Schweizer, Ivo Steinmetz, Gladys Tan, Patrick Tan, W. Joost Wiersinga, Vanaporn Wuthiekanun, Theresa L. Smith
Publikováno v: Emerging Infectious Diseases, Vol 18, Iss 12, Pp - (2012)
The US Public Health Emergency Medical Countermeasures Enterprise convened subject matter experts at the 2010 HHS Burkholderia Workshop to develop consensus recommendations for postexposure prophylaxis against and treatment for Burkholderia pseudomal
Externí odkaz: https://doaj.org/article/5202ba97436b4303bc57bfb60f85d843
Zobrazit plný text záznamu
4
Surgical Management of Lower Extremity Pyoderma Gangrenosum With Viable Cryopreserved Umbilical Tissue: A Case Series
Autor: Robert, Fridman, Tzvi, Bar-David, Joseph, Larsen, Andrew R, Olson
Publikováno v: Wounds : a compendium of clinical research and practice. 32(4)
Pyoderma gangrenosum (PG) is a rare skin disease that often presents as a uniquely painful and necrotic ulceration of the lower extremity. Pyoderma gangrenosum is often misdiagnosed and can have deleterious consequences to the patient, as there is no
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::74fdc024b716cba7713b8b5b12a026be
https://pubmed.ncbi.nlm.nih.gov/32155119
Zobrazit plný text záznamu
5
Economic Incentives for Antibacterial Drug Development: Literature Review and Considerations From the Transatlantic Task Force on Antimicrobial Resistance: Table 1
Autor: Kimberly Sciarretta, Joseph Larsen, John-Arne Røttingen, Arjon J. van Hengel, Aleksandra Opalska
Publikováno v: Clinical Infectious Diseases. 63:1470-1474
The Trans-Atlantic Task Force on Antimicrobial Resistance (TATFAR) in 2015 was tasked with exploring economic incentives for antibacterial drug development and providing recommendations for potential global implementation. Due to the continual declin
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::70c92aede9502d1ee1524e9f485ea881
https://doi.org/10.1093/cid/ciw593
Zobrazit plný text záznamu
6
Use of administrative data to increase the practicality of clinical trials: Insights from the Women’s Health Initiative
Autor: Joseph Larsen, Pamela A. Shaw, Carolyn J Burns, Garnet L. Anderson
Publikováno v: Clinical Trials. 13:519-526
Background: To reduce research costs in the context of pragmatic trials, consideration is given to using administrative data (Medicare claims) to ascertain clinical outcomes. Methods: In the historical context of the Women’s Health Initiative, the
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a22a505e05e4667a7567e01f8d7ace9
https://doi.org/10.1177/1740774516656579
Zobrazit plný text záznamu
7
Uncovering the Genomic Origins of Life
Autor: James A. Lake, Janet S. Sinsheimer, Joseph Larsen, Dan Thy Tran
Publikováno v: Lake, JA; Larsen, J; Tran, DT; & Sinsheimer, JS. (2018). Uncovering the Genomic Origins of Life. GENOME BIOLOGY AND EVOLUTION, 10(7), 1705-1714. doi: 10.1093/gbe/evy129. UCLA: Retrieved from: http://www.escholarship.org/uc/item/06j9643w
Genome Biology and Evolution
Genome biology and evolution, vol 10, iss 7
The Origin of Life Domain (OLD) is the period during which life on Earth began. Here, we derive and use a new phylogenetic algorithm to analyze Protein Families in order to reconstruct the chronological steps by which the OLD evolved. During this per
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e2fbfeaee0da6411cb561245d52fafa0
http://www.escholarship.org/uc/item/06j9643w
Zobrazit plný text záznamu
8
Pull Incentives for Antibacterial Drug Development: An Analysis by the Transatlantic Task Force on Antimicrobial Resistance
Autor: Aleksandra Opalska, Arjon J. van Hengel, Joseph Larsen, John-Arne Røttingen, Christine Årdal
Publikováno v: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 65(8)
New alternative market models are needed to incentivize companies to invest in developing new antibacterial drugs. In a previous publication, the Transatlantic Task Force on Antimicrobial Resistance (TATFAR) summarized the key areas of consensus for
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ccf93f8dcf5b37bce864076de494a9b1
https://pubmed.ncbi.nlm.nih.gov/29017240
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje